[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349095-105":59,"doc-detail-349095-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","induction-of-caspase-mediated-suppression-of-interferon-signaling-potentiates-viral-oncolysis-of-resistant-tumor-cells","Induction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells","","Tumors and cancer cells show heterogeneous interferon (IFN) pathway activity and interferon-stimulated gene (ISG) expression, which aligns with different susceptibilities to oncolytic viruses (OVs). A key hurdle in oncolytic virotherapy is selectively dampening IFN responses in malignant cells to widen OV efficacy. This study uses BH3 mimetics and caspase-mediated IFN inhibition to enhance OV-resistant tumor killing, using bladder cancer and melanoma models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/induction-of-caspase-mediated-suppression-of-interferon-signaling-potentiates-viral-oncolysis-of-resistant-tumor-cells/349095/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/induction-of-caspase-mediated-suppression-of-interferon-signaling-potentiates-viral-oncolysis-of-resistant-tumor-cells/349095.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in oncolytic virotherapy?","Question",{"text":112,"@type":113},"It addresses the difficulty of expanding therapeutic effectiveness when tumors mount strong antiviral interferon responses that limit oncolytic virus replication and killing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the proposed strategy enhance oncolytic virus activity in resistant tumor cells?",{"text":117,"@type":113},"It combines BH3 mimetic treatment with caspase-mediated suppression of IFN-mediated antiviral responses, enabling productive oncolytic virus infection in tumor cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanistic changes are induced by the BH3 mimetic Abt737?",{"text":121,"@type":113},"Abt737 activates caspases and promotes caspase-dependent cleavage of STAT1 (and IRF3 in specific cells), disrupting IFN/JAK/STAT signaling and IFN induction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349095,1790153862,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Bozhdansky etal. Cell Communication and Signaling (2026) 24:260  \n[https://doi.org/10.1186/s12964-026-02823-1](https://doi.org/10.1186/s12964-026-02823-1)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nInduction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells  \nVladimir Bozhdansky 1, Shelly Tayar 1, Shlomi Kashkash 1, Eran Bacharach 1 and Marcelo Ehrlich 1*  \nAbstract  \nTumors and cancer cell lines exhibit varying levels of activation in interferon (IFN) pathways and expression of IFN-stimulated genes (ISGs) . This heterogeneity correlates with differential susceptibility to oncolytic viruses (OVs), which exploit impaired IFN responses to replicate in and kill malignant cells preferentially. A current challenge in oncolytic virotherapy (OVT) is to develop strategies that selectively inhibit IFN responses in malignant cells, thereby expanding the therapeutic range of OVs. This study proposes leveraging the vulnerability of tumor cells to BH3 mimetic compounds and caspase-mediated inhibition of IFN responses to enhance OVT in OV-resistant tumors. Analysis of the bladder cancer (BC) cohort from The Cancer Genome Atlas (TCGA) revealed a cluster of antiviral ISGs exhibiting positively correlated expression, and subpopulations of high-and low ISG expressors. A similar pattern was observed in the urinary tract cohort of the Cancer Cell Line Encyclopedia (CCLE), suggesting that this ISG expression profile is regulated in a cell-autonomous manner. We study two BC cell lines, T24 and UMUC3, differing in ISG expression, and SKMEL3 melanoma cells, a non-BC cell line with features similar to T24 . T24 and SKMEL3 cells exhibited Janus kinase (JAK)-dependent resistance to the oncolytic orbivirus Epizootic Hemorrhagic Disease Virus Tel Aviv University (EHDV-TAU) . Treatment with the BH3 mimetic Abt737 activated caspases, suppressed IFN-mediated antiviral responses, and enabled productive EHDV-TAU infection in tumor cells but not in normal fibroblasts. Mechanistically, Abt737 induced caspase-dependent cleavage of signal transduction Signal Transducer and Activator of Transcription 1 (STAT1) in both cell lines and interferon regulatory factor 3 (IRF3) in T24 cells, suggesting disruption of IFN/JAK/STAT signaling and IFN induction. In these cells, the EHDVTAU + Abt737 combination increased the plasma membrane exposure of cal reticulin and extracellular ATP, markers of immunogenic cell death. In contrast, combining Abt737 with a mutant vesicular stomatitis virus (VSVΔ51M) reduced viral titers, indicating virus-specific effects. This strategy appears optimal for OVs like EHDV-TAU, which thrive in apoptotic environments. Overall, this approach may broaden OVT’s therapeutic reach by leveraging apoptosis to overcome tumor antiviral resistance.  \nPlain English summary  \nIn this study, we investigate a novel cancer treatment strategy that combines BH3 mimetics, drugs that trigger cancer cell death, with oncolytic viruses, which selectively infect and kill cancer cells. While promising, virus-based  \n*Correspondence: Marcelo Ehrlich [marceloe@tauex.tau.ac.il](marceloe@tauex.tau.ac.il)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is","cbCaikMD2vxBwhvL","https://ap.wps.com/l/cbCaikMD2vxBwhvL","pdf",3042922,18,"English","# Abstract\n## Study rationale and therapeutic challenge\n## Proposed strategy and experimental approach\n## Mechanistic findings and immune-related effects\n## Overall implications for oncolytic virotherapy","[{\"question\":\"What problem does the study address in oncolytic virotherapy?\",\"answer\":\"It addresses the difficulty of expanding therapeutic effectiveness when tumors mount strong antiviral interferon responses that limit oncolytic virus replication and killing.\"},{\"question\":\"How does the proposed strategy enhance oncolytic virus activity in resistant tumor cells?\",\"answer\":\"It combines BH3 mimetic treatment with caspase-mediated suppression of IFN-mediated antiviral responses, enabling productive oncolytic virus infection in tumor cells.\"},{\"question\":\"What mechanistic changes are induced by the BH3 mimetic Abt737?\",\"answer\":\"Abt737 activates caspases and promotes caspase-dependent cleavage of STAT1 (and IRF3 in specific cells), disrupting IFN/JAK/STAT signaling and IFN induction.\"}]","Induction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells | PDF",1790081605,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d033ef3cac7e807158dced4535110302.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf8af03044769522933f6f6074e7cec2.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7563e53bf2424f7efaffbb297a3c7846.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7dd93591c1dcb1d9c4e00f918387012.webp",980,1306]